Harvard Apparatus Regenerative Technology, Inc. (HRGN) — 10-Q Filings
All 10-Q filings from Harvard Apparatus Regenerative Technology, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
HRGN's Cash Dwindles Amidst Mounting Losses, Going Concern Doubt Raised
— Nov 7, 2025 Risk: high
Harvard Apparatus Regenerative Technology, Inc. (HRGN) reported a net loss of $1.7 million for the three months ended September 30, 2025, an improvement from a -
HRGN Reports No Revenue, Continues Burn Rate in Q2
— Aug 11, 2025 Risk: high
Harvard Apparatus Regenerative Technology, Inc. (HRGN) reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year peri -
Harvard Apparatus Regenerative Tech Q1 2025 Update
— May 14, 2025 Risk: medium
Harvard Apparatus Regenerative Technology, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $15,918,979 and total -
Harvard Apparatus Regenerative Technology Files 10-Q
— Nov 13, 2024 Risk: medium
Harvard Apparatus Regenerative Technology, Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine -
Harvard Apparatus Regenerative Tech Files Q2 2024 10-Q
— Aug 13, 2024 Risk: medium
Harvard Apparatus Regenerative Technology, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Biostage, Inc., reported its -
Harvard Apparatus Regenerative Technology, Inc. Files 10-Q for Period Ending March 31, 2024
— May 13, 2024 Risk: low
Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. The filing is a 10-Q for Harvard Apparatus
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX